Volume 13, Number 6—June 2007
Dispatch
Full Recovery from Baylisascaris procyonis Eosinophilic Meningitis
Table
Year of onset | Location | Age | Sex | Blood eos/ mm3, n (%)† | CSF eos/ mm3, n (%)† | Diagnostic method | Outcome |
---|---|---|---|---|---|---|---|
1975 | Missouri | 18 mo | Female | 5,139 (30) | 209 (80) | Serologic (cross-reacting) | Persistent weakness and spastic right arm and leg |
1980 | Pennsylvania | 10 mo | Male | 4,698 (27) | 63 (68) | Autopsy, serologic | Death |
1984 | Illinois | 18 mo | Male | 3,700 (37) | 220 (80) | Autopsy, serologic | Death |
1990 | New York | 13 mo | Male | 6,513 (39) | 75 (60) | Serologic | Neurologic deficits, cortical blindness, brain atrophy |
1993 | Michigan | 9 mo | Male | Unknown | Unknown | Serologic | Neurologic deficits, cortical blindness |
1993 | California | 13 mo | Male | 12,780 (45) | Not done | Brain biopsy, serologic | Neurologic deficits, blindness, seizures, brain atrophy |
1996 | Illinois | 6 y | Male | 605 (5) | 2 (<1) | Serologic | Neurologic deficits, seizures |
1996 | Minnesota | 13 mo | Male | 7,035 (35) | 3 (54) | Serologic | Death |
1997 | Minnesota | 19 mo | Male | 2,232 (18) | 5 (4) | Serologic | Death |
1998 | California | 11 mo | Male | 3,111 (17) | 1 (7) | Serologic | Neurologic deficits, seizures, profound visual impairment |
2000 | Illinois | 2.5 y | Male | 5,880 (28) | 26 (32) | Serologic | Neurologic deficits, blindness, generalized spasticity |
2000 | California | 17 y | Male | 2,385 (15) | 7 (37) | Brain biopsy, serologic | Death |
2002 | California | 11 mo | Male | Unknown | Unknown | Serologic | Neurologic deficits, cortical blindness, seizures |
2004‡ | Louisiana | 4 y | Male | 1,920 (12) | 954 (55) | Serologic | Full recovery |
References
- Michaels MG. Eosinophilic meningitis. In: Long SS, Pickering LK, Prober CG, editors. Principles and practice of pediatric infectious diseases. 2nd ed. Philadelphia: Churchill Livingston; 2003:312–5.
- Kazacos KR. Baylisascaris procyonis and related species. In: Samuel WM, Pybus MJ, Kocan AA, editors. Parasitic diseases of wild mammals. 2nd ed. Ames (IA): Iowa State University Press; 2001:301–41.
- Murray WJ, Kazacos KR. Raccoon roundworm encephalitis. Clin Infect Dis. 2004;39:1484–92. DOIPubMedGoogle Scholar
- Nuamtanong S. The evaluation of the 29 and 31 kDa antigens in female Angiostrongylus cantonensis for serodiagnosis of human angiostrongyliasis. Southeast Asian J Trop Med Public Health. 1996;27:291–6.PubMedGoogle Scholar
- Sorvillo F, Ash LR, Berlin OG, Morse SA. Baylisascaris procyonis: an emerging helminthic zoonosis. Emerg Infect Dis. 2002;8:355–9. DOIPubMedGoogle Scholar
- Gavin PJ, Kazacos KR, Shulman ST. Baylisascariasis. Clin Microbiol Rev. 2005;18:703–18. DOIPubMedGoogle Scholar
- Roussere GP, Murray WJ, Raudenbush CB, Kutilek MJ, Levee DJ, Kazacos KR. Raccoon roundworm eggs near homes and risk for larva migrans disease, California communities. Emerg Infect Dis. 2003;9:1516–22.PubMedGoogle Scholar
- Brinkman WB, Kazacos KR, Gavin PJ, Binns HJ, Robichaud JD, O’Gorman M, Seroprevalence of Baylisascaris procyonis (raccoon roundworm) in Chicago area children. In: Program and abstracts of the 2003 Annual Meeting of the Pediatric Academic Societies, Seattle, Washington; 2003 May 3–6. Abstract 1872 [cited 2007 Mar 29]. Available from http://www.abstracts2view.com/pasall/authorindex.php)
- Taylor MR, Keane CT, O’Connor P, Mulvihill E, Holland C. The expanded spectrum of toxocaral disease. Lancet. 1988;1:692–4. DOIPubMedGoogle Scholar
- Kazacos KR. Protecting children from helminthic zoonoses. Contemp Pediatr. 2000;17(Suppl):1–24.
- Boyce WM, Asai DJ, Wilder JK, Kazacos KR. Physicochemical characterization and monoclonal and polyclonal antibody recognition of Baylisascaris procyonis larval excretory-secretory antigens. J Parasitol. 1989;75:540–8. DOIPubMedGoogle Scholar
Page created: May 31, 2011
Page updated: May 31, 2011
Page reviewed: May 31, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.